Author： Pearce Lyndsay Ghosh Jonathan Counsell Andrew Serracino-Inglott Ferdinand
Publisher： Informa Healthcare
ISSN： 1465-6566
Source： Expert Opinion on Pharmacotherapy, Vol.9, Iss.15, 2008-10, pp. : 2683-2690
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Hypertension in Peripheral Arterial Disease
Current Pharmaceutical Design, Vol. 10, Iss. 29, 2004-11 ,pp. :
Access to resources
Recommend
Antioxidants in Peripheral Arterial Disease
Current Drug Targets, Vol. 4, Iss. 8, 2003-11 ,pp. :
Emerging drugs in peripheral arterial disease
By Tulsyan Nirman Ouriel Kenneth Kashyap Vikram S
Expert Opinion on Emerging Drugs, Vol. 11, Iss. 1, 2006-03 ,pp. :
Lipid Management and Peripheral Arterial Disease
Current Drug Targets, Vol. 8, Iss. 4, 2007-04 ,pp. :
Inflammation in Peripheral Arterial Disease (PAD)
Current Pharmaceutical Design, Vol. 18, Iss. 28, 2012-09 ,pp. :